North America Digital Therapeutics Market: Industry Analysis and Market Forecast (2019-2026) -by Sales Channel, by Application, and by Geography

North America Digital Therapeutics Market is expected to reach US$ 7,833 Mn by 2026 from US$ XX Mn in 2018 at CAGR of XX% during a forecast period. North America Digital Therapeutics Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. North America Digital Therapeutics market is segmented by Sales channel, By Application & by Geography. Sales channel is classified into B2B & B2C. By application market is divided into Preventive Applications, Treatment/Care-Related Applications. Digital therapeutics, commonly known as software for drugs has been increasing much attention due to the number of benefits it offers to patients that utilize it. Continuous monitoring of patient’s vital stats, ability to ensure adherence to medications, prompt reminders are some of the most important drivers offered by digital therapeutics. Rising in the internet usage and dependency over smartphones, digital therapeutics offers easy tracking and monitoring of patients and their vital stats without intervention. On the basis of sale channel. Sales channel segment is bifurcated as B2B and B2C. B2B segment is expected to lead the market growth. This growth is attributed to rising adoption of digital therapeutics in this segment, especially among payers and employers. Based on application, Preventive application segment is expected to dominate the market growth owing to, increasing government initiatives to increase the focus on preventive healthcare and a rising consensus among policymakers. North America is one of the major markets for Digital Therapeutics globally where U.S. and Canada are the two major regions profiled under this report. The U.S. has been reported to spend USD 3.2 trillion a year on healthcare. In order to control this expense, there is a rising focus on preventive healthcare, to indorse overall patient wellness as an alternative of medical treatment. Key players operates on the market are, Evolent Health, Inc., Pear Therapeutics, Inc. WellDoc Inc. Nanobiosym, Inc., Twine Health, Inc.,Mango Health Inc., Canary Health Inc., 2morrow Inc., Propeller Health, Ginger.Io, Inc., Noom Inc., Livongo Health, Omada Health, Inc., Proteus Digital Health, Inc.

Scope of the North America Digital Therapeutics Market: Inquire before buying

North America Digital Therapeutics market, By Sale channel

• B2B • B2C

North America Digital Therapeutics Market, By Application

• Preventive Applications • Treatment/Care-Related Applications

North America Digital Therapeutics market, By Region

• North America • U.S. • Canada

Key Players operating in the North America Digital Therapeutics market

• Evolent Health, Inc. • Pear Therapeutics, Inc. • WellDoc Inc. • Nanobiosym, Inc. • Twine Health, Inc. • Mango Health Inc. • Canary Health Inc. • 2morrow Inc. • Propeller Health • Ginger.Io, Inc. • Noom Inc. • Livongo Health • Omada Health, Inc. • Proteus Digital Health, Inc. • Fitbit, Inc. • Better Therapeutics, Inc. • Happify, Inc. • SAMSUNG • Ayogo Health Inc. • Smartpatient gmbh • Akili Interactive Labs, Inc.

North America Digital Therapeutics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. North America Digital Therapeutics Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. North America Digital Therapeutics Market Analysis and Forecast 5.1. North America Digital Therapeutics Market Analysis and Forecast 5.2. North America Digital Therapeutics Market Size& Y-o-Y Growth Analysis 5.2.1. North America 6. North America Digital Therapeutics Market Analysis and Forecast, by Sale Channel 6.1. Introduction and Definition 6.2. Key Findings 6.3. North America Digital Therapeutics Market Value Share Analysis, by Sale Channel 6.4. Market Size (US$ Mn) Forecast, by Sale Channel 6.5. Digital Therapeutics Market Analysis, by Sale Channel 6.6. North America Digital Therapeutics Market Attractiveness Analysis, by Sale Channel 7. North America Digital Therapeutics Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. North America Digital Therapeutics Market Value Share Analysis, by Application 7.3. Market Size (US$ Mn) Forecast, by Application 7.4. North America Digital Therapeutics Market Analysis, by Application 7.5. North America Digital Therapeutics Market Attractiveness Analysis, by Application 8. North America Digital Therapeutics Market Analysis, by Region 8.1. North America Digital Therapeutics Market Value Share Analysis, by Region 8.2. Market Size (US$ Mn) Forecast, by Region 8.3. North America Digital Therapeutics Market Attractiveness Analysis, by Region 9. North America Digital Therapeutics Market Analysis 9.1. Key Findings 9.2. North America Digital Therapeutics Market Overview 9.3. North America Digital Therapeutics Market Value Share Analysis, by Sale Channel 9.4. North America Digital Therapeutics Market Forecast, by Sale Channel 9.4.1. B2B 9.4.2. B2C 9.5. North America Digital Therapeutics Market Value Share Analysis, by Application 9.6. North America Digital Therapeutics Market Forecast, by Application 9.6.1. Preventive Applications 9.6.2. Treatment/Care-Related Applications 9.7. North America Digital Therapeutics Market Value Share Analysis, by Country 9.8. North America Digital Therapeutics Market Forecast, by Country 9.8.1. U.S 9.8.2. Canada 9.8.3. Rest of North America 9.9. North America Digital Therapeutics Market Analysis, by Country/ Sub-region 9.10. U.S Digital Therapeutics Market Forecast, by Sale Channel 9.10.1. B2B 9.10.2. B2C 9.11. U.S Digital Therapeutics Market Forecast, by Application 9.11.1. Preventive Applications 9.11.2. Treatment/Care-Related Applications 9.12. Canada Digital Therapeutics Market Forecast, by Sale Channel 9.12.1. B2B 9.12.2. B2C 9.13. Canada Digital Therapeutics Market Forecast, by Application 9.13.1. Preventive Applications 9.13.2. Treatment/Care-Related Applications 9.14. Rest of North America Digital Therapeutics Market Forecast, by Sale Channel 9.14.1. B2B 9.14.2. B2C 9.15. Rest of North America Digital Therapeutics Market Forecast, by Application 9.15.1. Preventive Applications 9.15.2. Treatment/Care-Related Applications 9.16. North America Digital Therapeutics Market Attractiveness Analysis 9.16.1. By Sale Channel 9.16.2. By Application 9.16.3. By Business Function 9.17. PEST Analysis 10. Company Profiles 10.1. Market Share Analysis, by Company 10.2. Competition Matrix 10.3. Company Profiles: Key Players 10.3.1. Evolent Health, Inc. 10.3.1.1. Company Overview 10.3.1.2. Financial Overview 10.3.1.3. Business Strategy 10.3.1.4. Recent Developments 10.3.1.5. Stock Management Footprint 10.3.2. Evolent Health, Inc. 10.3.3. Pear Therapeutics, Inc. 10.3.4. WellDoc Inc. 10.3.5. Nanobiosym, Inc. 10.3.6. Twine Health, Inc. 10.3.7. Mango Health Inc. 10.3.8. Canary Health Inc. 10.3.9. 2morrow Inc. 10.3.10. Propeller Health 10.3.11. Ginger.Io, Inc. 10.3.12. Noom Inc. 10.3.13. Livongo Health 10.3.14. Omada Health, Inc. 10.3.15. Proteus Digital Health, Inc. 10.3.16. Fitbit, Inc. 10.3.17. Better Therapeutics, Inc. 10.3.18. Happify, Inc. 10.3.19. SAMSUNG 10.3.20. Ayogo Health Inc. 10.3.21. Smartpatient gmbh 10.3.22. Akili Interactive Labs, Inc. 11. Primary Key Insights

About This Report

Report ID 7077
Category Information Technology & Telecommunication
Published Date Nov 2019
Updated Date oct 2020
Contact Us